| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.25 | 0.0001 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |